Cargando…

Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers

The ultraconserved regions (UCRs) are 481 genomic elements, longer than 200 bp, 100% conserved in human, mouse, and rat genomes. Usually, coding regions are more conserved, but more than 80% of UCRs are either intergenic or intronic, and many of them produce long non-coding RNAs (lncRNAs). Recently,...

Descripción completa

Detalles Bibliográficos
Autor principal: de Oliveira, Jaqueline Carvalho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829027/
https://www.ncbi.nlm.nih.gov/pubmed/36622962
http://dx.doi.org/10.1590/1678-4685-GMB-2022-0125
_version_ 1784867390312415232
author de Oliveira, Jaqueline Carvalho
author_facet de Oliveira, Jaqueline Carvalho
author_sort de Oliveira, Jaqueline Carvalho
collection PubMed
description The ultraconserved regions (UCRs) are 481 genomic elements, longer than 200 bp, 100% conserved in human, mouse, and rat genomes. Usually, coding regions are more conserved, but more than 80% of UCRs are either intergenic or intronic, and many of them produce long non-coding RNAs (lncRNAs). Recently, the deregulated expression of transcribed UCRs (T-UCRs) has been associated with pathological conditions. But, differently from many lncRNAs with recognized crucial effects on malignant cell processes, the role of T-UCRs in the control of cancer cell networks is understudied. Furthermore, the potential utility of these molecules as molecular markers is not clear. Based on this information, the present review aims to organize information about T-UCRs with either oncogenic or tumor suppressor role associated with cancer cell signaling, and better describe T-UCRs with potential utility as prognosis markers. Out of 481 T-UCRs, 297 present differential expression in cancer samples, 23 molecules are associated with tumorigenesis processes, and 12 have more clear potential utility as prognosis markers. In conclusion, T-UCRs are deregulated in several tumor types, highlighted as important molecules in cancer networks, and with potential utility as prognosis markers, although further investigation for translational medicine is still needed.
format Online
Article
Text
id pubmed-9829027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedade Brasileira de Genética
record_format MEDLINE/PubMed
spelling pubmed-98290272023-01-10 Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers de Oliveira, Jaqueline Carvalho Genet Mol Biol Young Brazilian Geneticists - Special Issue The ultraconserved regions (UCRs) are 481 genomic elements, longer than 200 bp, 100% conserved in human, mouse, and rat genomes. Usually, coding regions are more conserved, but more than 80% of UCRs are either intergenic or intronic, and many of them produce long non-coding RNAs (lncRNAs). Recently, the deregulated expression of transcribed UCRs (T-UCRs) has been associated with pathological conditions. But, differently from many lncRNAs with recognized crucial effects on malignant cell processes, the role of T-UCRs in the control of cancer cell networks is understudied. Furthermore, the potential utility of these molecules as molecular markers is not clear. Based on this information, the present review aims to organize information about T-UCRs with either oncogenic or tumor suppressor role associated with cancer cell signaling, and better describe T-UCRs with potential utility as prognosis markers. Out of 481 T-UCRs, 297 present differential expression in cancer samples, 23 molecules are associated with tumorigenesis processes, and 12 have more clear potential utility as prognosis markers. In conclusion, T-UCRs are deregulated in several tumor types, highlighted as important molecules in cancer networks, and with potential utility as prognosis markers, although further investigation for translational medicine is still needed. Sociedade Brasileira de Genética 2023-01-09 /pmc/articles/PMC9829027/ /pubmed/36622962 http://dx.doi.org/10.1590/1678-4685-GMB-2022-0125 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Young Brazilian Geneticists - Special Issue
de Oliveira, Jaqueline Carvalho
Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title_full Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title_fullStr Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title_full_unstemmed Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title_short Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers
title_sort transcribed ultraconserved regions: new regulators in cancer signaling and potential biomarkers
topic Young Brazilian Geneticists - Special Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829027/
https://www.ncbi.nlm.nih.gov/pubmed/36622962
http://dx.doi.org/10.1590/1678-4685-GMB-2022-0125
work_keys_str_mv AT deoliveirajaquelinecarvalho transcribedultraconservedregionsnewregulatorsincancersignalingandpotentialbiomarkers